"This is a custom made vaccine from the patient's own tumor cells which is designed to activate the patient's own defenses to fight the tumor where it had not done that before, " said NCI's Dr. Larry Kwak.
Provenge fans, who include many individual investors and some patients, often try to paint Provenge, the first therapeutic cancer vaccine, as the be-all-and-end-all of tumor-stopping.